Advertisement
Screener

Quanterix Corporation (QTRX) Operating Leases, Rent Expense

2.8 / 5 stars · 68/120 Roast Me

Quanterix Corporation Operating Leases, Rent Expense

Quanterix Corporation (QTRX) reported Operating Leases, Rent Expense of $3.30 million for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-05.

Discontinued › Expense Statement › Operating Expenses

us-gaap:LeaseAndRentalExpense · last filed 2021-03-05

  • Quanterix Corporation operating leases, rent expense for the quarter ending 2019-12-31 was $700.00K, a 16.67% increase year-over-year.
  • Quanterix Corporation operating leases, rent expense for the quarter ending 2019-09-30 was $700.00K, a 75.00% increase year-over-year.
  • Quanterix Corporation operating leases, rent expense for the quarter ending 2019-06-30 was $900.00K, a 125.00% increase year-over-year.
  • Quanterix Corporation operating leases, rent expense for the quarter ending 2019-03-31 was $1.00M, a 233.33% increase year-over-year.
  • Quanterix Corporation operating leases, rent expense for fiscal 2019 was $3.30M, a 106.25% increase from fiscal 2018.
  • Quanterix Corporation operating leases, rent expense for fiscal 2018 was $1.60M, a 45.45% increase from fiscal 2017.
  • Quanterix Corporation operating leases, rent expense for fiscal 2017 was $1.10M, a 0.00% change from fiscal 2016.
  • Quanterix Corporation operating leases, rent expense for fiscal 2016 was $1.10M.
Period endOperating Leases, Rent Expense 3 monthOperating Leases, Rent Expense 6 monthOperating Leases, Rent Expense 9 monthOperating Leases, Rent Expense 12 month
2019-12-31$700.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05
$1.40M
derived: sum of 2 quarters · filed 2021-03-05
$2.30M
derived: sum of 3 quarters · filed 2021-03-05
$3.30M
10-K · filed 2021-03-05
2019-09-30$700.00K
10-Q · filed 2019-11-08
$1.60M
derived: sum of 2 quarters · filed 2019-11-08
$2.60M
10-Q · filed 2019-11-08
$3.20M
derived: sum of 4 quarters · filed 2021-03-05
2019-06-30$900.00K
10-Q · filed 2019-08-06
$1.90M
10-Q · filed 2019-08-06
$2.50M
derived: sum of 3 quarters · filed 2021-03-05
$2.90M
derived: sum of 4 quarters · filed 2021-03-05
2019-03-31$1.00M
10-Q · filed 2019-05-10
$1.60M
derived: sum of 2 quarters · filed 2021-03-05
$2.00M
derived: sum of 3 quarters · filed 2021-03-05
$2.40M
derived: sum of 4 quarters · filed 2021-03-05
2018-12-31$600.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05
$1.00M
derived: sum of 2 quarters · filed 2021-03-05
$1.40M
derived: sum of 3 quarters · filed 2021-03-05
$1.60M
10-K · filed 2021-03-05
2018-09-30$400.00K
10-Q · filed 2019-11-08
$800.00K
derived: sum of 2 quarters · filed 2019-11-08
$1.00M
10-Q · filed 2019-11-08
$1.40M
derived: sum of 4 quarters · filed 2020-03-13
2018-06-30$400.00K
10-Q · filed 2019-08-06
$700.00K
10-Q · filed 2019-08-06
$1.00M
derived: sum of 3 quarters · filed 2020-03-13
$1.20M
derived: sum of 4 quarters · filed 2020-03-13
2018-03-31$300.00K
10-Q · filed 2019-05-10
$600.00K
derived: sum of 2 quarters · filed 2020-03-13
$800.00K
derived: sum of 3 quarters · filed 2020-03-13
$1.10M
derived: sum of 4 quarters · filed 2020-03-13
2017-12-31$300.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13
$500.00K
derived: sum of 2 quarters · filed 2020-03-13
$800.00K
derived: sum of 3 quarters · filed 2020-03-13
$1.10M
10-K · filed 2020-03-13
2017-09-30$200.00K
10-Q · filed 2018-11-07
$500.00K
derived: sum of 2 quarters · filed 2018-11-07
$800.00K
10-Q · filed 2018-11-07
2017-06-30$300.00K
10-Q · filed 2018-08-10
$600.00K
10-Q · filed 2018-08-10
2017-03-31$300.00K
10-Q · filed 2018-05-15
2016-12-31$1.10M
10-K · filed 2019-03-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
EyePoint, Inc. (EYPT)United States$0.314B-3.96
908 Devices Inc. (MASS)United States$0.476B-9.53
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15